New York State Common Retirement Fund’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Other funds holding SEEL
GJL
UIC
MCM
OMC
New York State Common Retirement Fund's SEEL Position: Q3 2022 in Review
New York State Common Retirement Fund held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3491.
New York State Common Retirement Fund first reported a position in SEEL in Q2 2021 and has held it in 4 quarters since. The position peaked at $171K in Q2 2021. 68 funds tracked by Wall St. Rank hold SEEL as of Q3 2022.
- New York State Common Retirement Fund held 0 shares of Seelos Therapeutics, Inc. Common Stock worth $0 as of Q3 2022.
- New York State Common Retirement Fund left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q3 2022.
- Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q3 2022, its #3491 holding.
- New York State Common Retirement Fund first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and has held it in 4 quarters since.
- New York State Common Retirement Fund's Seelos Therapeutics, Inc. Common Stock position peaked at $171K in Q2 2021.
- 68 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2022.
Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.